Evommune, sell signal in week 19
Evommune -1.2%: after a 32% jump, the rebound stalls below the Inversion Point
Our view last week
After 10 straight down weeks, Evommune stock lifts its head with a 32% jump: the price brushes its low in the 4.9 area again, then takes off and closes in the upper part of the weekly range. On technical analysis the signal stays a sell and the price action bearish, with money flow still negative, but the short's gain shrinks from over 60% to 48% and the price is closing in on the Inversion Point, in the 7.1 area. What matters now is whether that level holds.
This week's summary
After a 32% jump, Evommune stock stalls below the Inversion Point: the week closes at -1.2%, after touching the daily upper Bollinger Band in the 6.9 area. On technical analysis the decline is still standing, with price action pointing to distribution and money flow negative for 29 weeks, though improving. Among the US stocks on a sell signal in our model, this one is in week 19, with the short up 48.7%, a trade setup now hinging on the 7.1 area.
IQS Phase
64
ordinary
Signal Strength
7
decline fading out
Sizing
STANDARD
Ranking
#149 / 181
US stocks
Trade P&L %
+48.69%
from signal to date, no stop loss
Evommune (EVMN) weekly chart — EMA50 · MACD · VWAP
Weekly chart · EMA50 · MACD · VWAP · Source: TradingView
Rank position
ranks 149th among the 181 sell signals for US stocks in our ranking, with a signal strength of 7 out of 100.
Sector context
SectorHealth Care
Benchmark ETFXLV
Sector regimein strong phase
Performanceweekly -0.04% · monthly +9.47%
EVMN belongs to the health care sector (reference ETF XLV). The sector is classified in strong phase according to our weekly reading.
restricted Platinum content